CHR HANSEN BIOSCIENCES RDI

Projektträger – zwischengeschaltetes Finanzinstitut

CHR. HANSEN HOLDING A/S

Ort

• Frankreich
• Dänemark

Beschreibung

Financing of Christian Hansen A/S's RDI for the development of bioscience-based ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.

Ziele

The project focuses on the research and development (R&D) activities of two of the promoter’s divisions with the most potential impact on health. It concerns the development of innovative solutions (i) to reduce sugar, salt and fat; and extend shelf life of food products for the Cultures & Enzymes division as well as (ii) to improve the stability of probiotic cultures, to protect agricultural crop or to explore bacterial applications to human health for the Health & Nutrition division.
The project will be implemented in the promoter’s existing R&D facilities in Denmark and France.

Sektor(en)

• Industrie

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

EUR 75 million

Gesamtkosten (voraussichtlicher Betrag)

EUR 200 million

Umweltaspekte

R&D activities included in the project will not materially change current practice and will be carried out within existing facilities and laboratories, pilot plants, etc. The R&D activities as such are not specifically listed in the Directive 2011/92/EU, therefore an Environmental Impact Assessment (EIA) should not be required by the competent authority. This, along with any other environmental details, will be verified during the appraisal.

Auftragsvergabe

The promoter is a private company not operating in the utilities sector and not having a status of a contracting authority. Thus it is not covered by EU Directives on procurement.

Projektstatus

Unterzeichnet - 11/12/2015